Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis
Arch Bronconeumol. 2022 Jun;58(6):474-481.
doi: 10.1016/j.arbres.2020.05.030.
Epub 2020 Jun 27.
[Article in
English,
Spanish]
Authors
Pedro J Marcos
1
, Cristina Represas Represas
2
, Cristina Ramos
2
, Blanca Cimadevila Álvarez
3
, Alberto Fernández Villar
2
, Angélica Fraga Liste
3
, Susana Fernández Nocelo
3
, Javier Quiles Del Río
3
, Carlos Zamarrón Sanz
4
, Rafael Golpe
5
, José Abal Arca
6
, Uxío Calvo Álvarez
7
, Sonia Pértega
8
, Julio García Comesaña
9
Affiliations
- 1 Servicio de Neumología, Dirección Asistencial, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Area Sanitaria da Coruña e Cee, Sergas, Universidade da Coruña (UDC), As Xubias, 15006 A Coruña, Spain. Electronic address: Pedro.jorge.marcos.rodriguez@sergas.es.
- 2 Servicio de Neumología, NeumoVigoI+i Research Group, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Hospital Álvaro Cunqueiro de Vigo, Sergas, Spain.
- 3 Servicio Galego de Saude (SERGAS), Santiago de Compostela, Galicia, Spain.
- 4 Servicio de Neumología, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), Sergas, Spain.
- 5 Servicio de Neumología, Hospital Universitario Lucus Augusti de Lugo, Sergas, Spain.
- 6 Servicio de Neumología, Complejo Hospitalario Universitario de Ourense (CHUOU), Sergas, Spain.
- 7 Sección de Neumología, Hospital Arquitecto Marcide de Ferrol, Sergas, Spain.
- 8 Epidemiology and Biostatistics Unit, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complejo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), As Xubias, 15006 A Coruña, Spain.
- 9 Xerencia, Estructura Organizativa Integrada (EOXI) de Vigo, Sergas, Spain.
Abstract
Introduction:
Currently there is lack of data regarding the impact of a home telehealth program on readmissions and mortality rate after a COPD exacerbation-related hospitalization.
Objective:
To demonstrate if a tele-monitoring system after a COPD exacerbation admission could have a favorable effect in 1-year readmissions and mortality in a real-world setting.
Methods:
This is an observational study where we compared an intervention group of COPD patients treated after hospitalization that conveyed a telehealth program with a followance period of 1 year with a control group of patients evaluated during one year before the intervention began. A propensity-score analyses was developed to control for confounders. The main clinical outcome was 1-year all-cause mortality or COPD-related readmission.
Results:
The analysis comprised 351 telemonitoring patients and 495 patients in the control group. The intervention resulted in less mortality or readmission after 12 months (35.2% vs. 45.2%; hazard ratio [HR] 0.71 [95% CI=0.56-0.91]; p=0.007). This benefit was maintained after the propensity score analysis (HR=0.66 [95% CI=0.51-0.84]). This benefit, which was seen from the first month of the study and during its whole duration, is maintained when mortality (HR=0.54; 95% CI=[0.36-0.82]) or readmission (subdistribution hazard ratio [SHR] 0.66; 95% CI=[0.50-0.86]) are analyzed separately.
Conclusion:
Telemonitoring after a severe COPD exacerbation is associated with less mortality or readmissions at 12 months in a real world clinical setting.
Keywords:
COPD; Exacerbation; Mortality; Readmission; Telemedicine; Telemonitoring.
Copyright © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.
MeSH terms
-
Disease Progression
-
Hospitalization
-
Humans
-
Patient Readmission
-
Propensity Score
-
Pulmonary Disease, Chronic Obstructive* / drug therapy
-
Telemedicine*